SCHEMBL21212935

SCHEMBL21212935

c1ccc(-n2c3ccccc3c3cc4ccc(-c5nc(-n6c7cc8ccccc8cc7c7ccc8ccccc8c76)nc6ccccc56)cc4cc32)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.37
KDM4E B2RXH2 3/20 0.37
ATM Q13315 2/20 0.37
ALDH1A1 P00352 3/20 0.35
HPGD P15428 3/20 0.35
MAPT P10636 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
LMNA P02545 2/20 0.33
MAPK1 P28482 2/20 0.33
POLB P06746 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
HTT P42858 1/20 0.32
F2 P00734 1/20 0.32
F10 P00742 1/20 0.32
PRSS1 P07477 1/20 0.32
SCN9A Q15858 3/20 0.31
PTGER4 P35408 1/20 0.31
PIK3CD O00329 1/20 0.31
PIK3CA P42336 1/20 0.31
MTOR P42345 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21168829 0.94 L3MBTL1 (0.37) L3MBTL1KDM4EATMALDH1A1HPGD
SCHEMBL21213817 0.94 ALDH1A1 (0.36) L3MBTL1KDM4EATMALDH1A1HPGD
SCHEMBL22425519 0.93 L3MBTL1 (0.38) L3MBTL1KDM4EATMALDH1A1HPGD
SCHEMBL19507475 0.93 L3MBTL1 (0.41) L3MBTL1KDM4EATMALDH1A1HPGD
SCHEMBL21717437 0.92 L3MBTL1 (0.34) L3MBTL1KDM4EATMALDH1A1HPGD
SCHEMBL19037149 0.92 ALDH1A1 (0.36) L3MBTL1KDM4EATMALDH1A1HPGD
SCHEMBL21213425 0.92 L3MBTL1 (0.42) L3MBTL1KDM4EATMALDH1A1HPGD
SCHEMBL21213313 0.92 L3MBTL1 (0.42) L3MBTL1KDM4EATMALDH1A1HPGD
SCHEMBL21717448 0.91 L3MBTL1 (0.33) L3MBTL1KDM4EATMALDH1A1HPGD
SCHEMBL21168895 0.90 KDM4E (0.36) L3MBTL1KDM4EATMALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11581496-B2 Benzocarbazole-based compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2023-02-14 US disclosed
US-20190237680-A1 BENZOCARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2019-08-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190237680-A1 BENZOCARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CYP1B1, CYP2C9, CYP3A4 L3MBTL1 898/4885KDM4E 879/4885ATM 4058/4885
US-11581496-B2 Benzocarbazole-based compound and organic light-emitting device comprising same CYP1B1, CYP2C9, CYP3A4 L3MBTL1 898/4885KDM4E 879/4885ATM 4058/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.